604 related articles for article (PubMed ID: 12766106)
1. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
[TBL] [Abstract][Full Text] [Related]
2. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
[TBL] [Abstract][Full Text] [Related]
3. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.
Hoffman RM; Shah JH; Wendel CS; Duckworth WC; Adam KD; Bokhari SU; Dalton C; Murata GH;
Diabetes Care; 2002 Oct; 25(10):1744-8. PubMed ID: 12351471
[TBL] [Abstract][Full Text] [Related]
4. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update.
Poolsup N; Suksomboon N; Rattanasookchit S
Diabetes Technol Ther; 2009 Dec; 11(12):775-84. PubMed ID: 20001678
[TBL] [Abstract][Full Text] [Related]
6. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
7. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
Harris MI;
Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
[TBL] [Abstract][Full Text] [Related]
8. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Hoffman RM; Duckworth WC; Wendel CS; Shah JH;
Am J Med Sci; 2004 Jun; 327(6):319-23. PubMed ID: 15201644
[TBL] [Abstract][Full Text] [Related]
9. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
10. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
12. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial.
Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG
J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147
[No Abstract] [Full Text] [Related]
13. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.
Kovatchev BP; Cox DJ; Kumar A; Gonder-Frederick L; Clarke WL
Diabetes Technol Ther; 2003; 5(5):817-28. PubMed ID: 14633347
[TBL] [Abstract][Full Text] [Related]
14. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
[TBL] [Abstract][Full Text] [Related]
15. The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study.
Chubb SA; Van Minnen K; Davis WA; Bruce DG; Davis TM
Diabetes Res Clin Pract; 2011 Dec; 94(3):371-6. PubMed ID: 21862165
[TBL] [Abstract][Full Text] [Related]
16. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study.
Halimi S; Charpentier G; Grimaldi A; Grenier JL; Baut F; Germain B; Magnette J
Diabetes Metab; 2001 Dec; 27(6):681-7. PubMed ID: 11852377
[TBL] [Abstract][Full Text] [Related]
17. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
Ziegler R; Eichholz R; Schulz B
J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
19. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
20. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
